Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


Company Profile for Galapagos NV (GLPG)

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Contact Information

Galapagos NV

Generaal De Wittelaan L11 A3
Mechelen, 2800
Phone: 32-15-34-29-00
Fax: 32-15-34-29-01

Key Executives for Galapagos NV (GLPG)

Onno Van De StolpeCEO/Executive DirectorBart FiliusChief Financial Officer
Piet WigerinckChief Scientific OfficerAndre HoekemaSenior VP:Corporate Dev
Chris NewtonMng Dir:BiofocusJohn MontanaMng Dir:Argenta
Philip DudfieldMng Dir:FideltaElizabeth GoodwinHead:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil